Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Retroperitoneal lymph-node dissection after chemotherapy for germ cell cancer in patients with elevated tumor markers

Nature Clinical Practice Urology volume 3, pages 250–251 (2006)Cite this article

boxed-textBeck SD et al. (2005) Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 23: 6149–6156

A subset of patients treated with chemotherapy for testicular nonseminoma, who have residual retroperitoneal masses and elevated tumor markers, should be considered for retroperitoneal lymph-node dissection

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hendry WF et al. (2002) Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 94: 1668–1676

    Article  Google Scholar 

  2. Christensen TB et al. (1999) Validation of 125I-hCG as a marker for elimination of hCG and stability of 125I-hCG after in vivo injection in humans. Br J Cancer 80: 1582–1587

    Article  CAS  Google Scholar 

  3. Fizazi K (2001) Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy—results from an international study group. J Clin Oncol 19: 2647–2657

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Consultant Clinical Oncologist at the Royal Marsden Hospital, and a Professor and the Radiotherapy Section Chairman at The Institute of Cancer Research,

    Alan Horwich & Robert Huddart

  2. Consultant Clinical Oncologist at the Royal Marsden Hospital, and the Team Leader of the Section of Radiotherapy at The Institute of Cancer Research, Sutton, Surrey, UK

    Alan Horwich & Robert Huddart

Authors
  1. Alan Horwich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Huddart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan Horwich.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horwich, A., Huddart, R. Retroperitoneal lymph-node dissection after chemotherapy for germ cell cancer in patients with elevated tumor markers. Nat Rev Urol 3, 250–251 (2006). https://doi.org/10.1038/ncpuro0481

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0481

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing